Skip to main content

TRAILR1/TNFRSF10A Products

TNF-related apoptosis-inducing ligand (TRAIL), also known as Apo-2 ligand and TNFSF10, is a type II transmembrane protein with a carboxy-terminal extracellular domain that exhibits homology to other TNF superfamily members.

TRAIL binds at least five different receptors: TRAILR1 (DR4), R2 (DR5), R3 (DcR1), R4 (DcR2), and osteoprotegerin (OPG). TRAIL receptors all exhibit cysteine-rich repeats characteristic of the TNF receptor superfamily. TRAILR1 and R2 are type 1 transmembrane proteins with intracellular death domains (DD) and, subsequently, have the ability to mediate TRAIL-induced apoptosis. The remaining receptors are decoys that may regulate TRAIL activity by competing for binding sites with TRAILR1 and R2.

TRAILR3 is membrane-associated via GPI linkage. TRAILR4 is a type 1 transmembrane receptor, but exhibits a truncated cytoplasmic domain. Like the active receptors TRAILR1 and R2, OPG has a DD motif but is a soluble protein.

Products:

 

Show More

323 results for "TRAILR1/TNFRSF10A" in Products

Back to Search Results
应用

323 results for "TRAILR1/TNFRSF10A" in Products

TRAILR1/TNFRSF10A Products

TNF-related apoptosis-inducing ligand (TRAIL), also known as Apo-2 ligand and TNFSF10, is a type II transmembrane protein with a carboxy-terminal extracellular domain that exhibits homology to other TNF superfamily members.

TRAIL binds at least five different receptors: TRAILR1 (DR4), R2 (DR5), R3 (DcR1), R4 (DcR2), and osteoprotegerin (OPG). TRAIL receptors all exhibit cysteine-rich repeats characteristic of the TNF receptor superfamily. TRAILR1 and R2 are type 1 transmembrane proteins with intracellular death domains (DD) and, subsequently, have the ability to mediate TRAIL-induced apoptosis. The remaining receptors are decoys that may regulate TRAIL activity by competing for binding sites with TRAILR1 and R2.

TRAILR3 is membrane-associated via GPI linkage. TRAILR4 is a type 1 transmembrane receptor, but exhibits a truncated cytoplasmic domain. Like the active receptors TRAILR1 and R2, OPG has a DD motif but is a soluble protein.

Products:

 

Show More
Applications: WB, IHC, Neut
Reactivity: Human
Applications: Flow, IHC, CyTOF-ready
Reactivity: Human
Applications: WB, ICC/IF, Flow, CyTOF-ready, Simple Western
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: WB, ICC/IF
Reactivity: Human, Mouse, Rat
Applications: Flow
Reactivity: Human
Applications: WB
Reactivity: Human
Applications: IHC, WB, ELISA, ICC/IF
Reactivity: Human, Mouse, Rat
Applications: Flow
Reactivity: Human
Applications: IHC, ICC/IF
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: BA
Applications: ICC/IF, Flow, IP, CyTOF-ready, Func
Reactivity: Human

Clone DR-4-02 was used by HLDA to establish CD designation.

Applications: IHC, Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: Flow
Reactivity: Human
Applications: AC
Applications: AC
Applications: ICC/IF
Reactivity: Human
Applications: Flow
Reactivity: Human

Recombinant Monoclonal Antibody

Applications: ELISA
Results Per Page
5 10 25 50
/ 13